BSI-201 (Iniparib)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BSI-201 (Iniparib), covering 2012-08-07 to 2016-03-17. Get the full timeline:
Most recent: Clinical Trial Update: A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer [Phase 2]